Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmas Say EU Nations Seize Indian Drugs Bound For Latin America

This article was originally published in PharmAsia News

Executive Summary

Indian drug makers are looking to bypass European ports when they ship their products to Latin American countries. The Pharmaceuticals Export Promotion Council in India said several drug makers have complained about their shipments being seized in some EU countries as their products pass through on their way to Latin America. Customs agents in France, Germany, The Netherlands and the United Kingdom have seized recent shipments based on the EU's new definition of counterfeit drugs and patent infringement. The drugs are legal in their destination country, the drug makers argue, and should be allowed to pass through Europe. (Click here for more

You may also be interested in...



India Opposes Seizure Of Drugs By EU Even As Dr. Reddy’s Labs Brings Its Goods Back

MUMBAI - Stung by strictures on Indian companies routing drug consignments through the European Union, the Indian government is considering drastic measures in a bid to control further damage to India's pharmaceutical trade

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel